| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebrovascular Circulation | 34 | 2021 | 430 | 3.780 |
Why?
|
| Homeostasis | 29 | 2017 | 683 | 2.970 |
Why?
|
| Cardiopulmonary Bypass | 10 | 2017 | 344 | 1.860 |
Why?
|
| Spectroscopy, Near-Infrared | 12 | 2017 | 133 | 1.740 |
Why?
|
| Monitoring, Intraoperative | 11 | 2017 | 128 | 1.550 |
Why?
|
| Intracranial Pressure | 17 | 2021 | 181 | 1.410 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2017 | 104 | 1.070 |
Why?
|
| Heart Defects, Congenital | 9 | 2019 | 1803 | 1.000 |
Why?
|
| Blood Pressure | 22 | 2021 | 1326 | 0.940 |
Why?
|
| Intracranial Hypertension | 6 | 2016 | 120 | 0.800 |
Why?
|
| Blood Flow Velocity | 16 | 2021 | 449 | 0.790 |
Why?
|
| Ataxia Telangiectasia | 2 | 2012 | 15 | 0.790 |
Why?
|
| Ventilators, Mechanical | 2 | 2011 | 35 | 0.750 |
Why?
|
| Noninvasive Ventilation | 1 | 2021 | 30 | 0.750 |
Why?
|
| Acute Lung Injury | 5 | 2018 | 62 | 0.720 |
Why?
|
| Intensive Care Units, Pediatric | 8 | 2021 | 470 | 0.690 |
Why?
|
| High-Frequency Ventilation | 2 | 2011 | 16 | 0.690 |
Why?
|
| Dexmedetomidine | 3 | 2009 | 44 | 0.670 |
Why?
|
| Arterial Pressure | 9 | 2019 | 103 | 0.640 |
Why?
|
| Lung | 8 | 2009 | 1465 | 0.640 |
Why?
|
| Pulmonary Ventilation | 2 | 2009 | 28 | 0.630 |
Why?
|
| Monitoring, Physiologic | 8 | 2016 | 364 | 0.600 |
Why?
|
| Anesthetics, Intravenous | 2 | 2008 | 47 | 0.600 |
Why?
|
| Middle Cerebral Artery | 7 | 2019 | 109 | 0.590 |
Why?
|
| Venous Pressure | 2 | 2014 | 8 | 0.560 |
Why?
|
| Brain Injuries | 6 | 2017 | 762 | 0.550 |
Why?
|
| Swine | 16 | 2021 | 1167 | 0.520 |
Why?
|
| Anesthetics | 2 | 2019 | 81 | 0.510 |
Why?
|
| Cardiac Surgical Procedures | 8 | 2019 | 1099 | 0.510 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2012 | 2058 | 0.510 |
Why?
|
| Optic Nerve | 2 | 2014 | 116 | 0.500 |
Why?
|
| Oximetry | 9 | 2013 | 160 | 0.490 |
Why?
|
| Hemoglobins | 3 | 2013 | 303 | 0.480 |
Why?
|
| Postoperative Complications | 6 | 2019 | 3020 | 0.470 |
Why?
|
| Blood Pressure Determination | 3 | 2019 | 105 | 0.460 |
Why?
|
| Pulmonary Circulation | 3 | 2009 | 121 | 0.460 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 196 | 0.440 |
Why?
|
| Hypothermia, Induced | 4 | 2017 | 161 | 0.440 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2017 | 233 | 0.430 |
Why?
|
| Coronary Vessels | 1 | 2017 | 527 | 0.420 |
Why?
|
| Lung Injury | 2 | 2011 | 122 | 0.410 |
Why?
|
| Cerebral Hemorrhage | 4 | 2019 | 144 | 0.400 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2013 | 169 | 0.400 |
Why?
|
| Infant, Newborn | 20 | 2019 | 8114 | 0.390 |
Why?
|
| Mass Casualty Incidents | 1 | 2011 | 17 | 0.380 |
Why?
|
| Hypoxia | 2 | 2019 | 248 | 0.380 |
Why?
|
| Perioperative Period | 1 | 2011 | 50 | 0.380 |
Why?
|
| Hypnotics and Sedatives | 2 | 2009 | 135 | 0.370 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2008 | 51 | 0.360 |
Why?
|
| Critical Illness | 3 | 2015 | 591 | 0.350 |
Why?
|
| Thrombosis | 2 | 2016 | 518 | 0.350 |
Why?
|
| Thromboembolism | 1 | 2011 | 84 | 0.340 |
Why?
|
| Extravascular Lung Water | 1 | 2009 | 2 | 0.340 |
Why?
|
| Thermodilution | 1 | 2009 | 10 | 0.340 |
Why?
|
| Deep Sedation | 1 | 2009 | 6 | 0.330 |
Why?
|
| Venous Thrombosis | 1 | 2011 | 179 | 0.330 |
Why?
|
| Intracranial Hemorrhages | 3 | 2013 | 73 | 0.330 |
Why?
|
| Chest Wall Oscillation | 1 | 2009 | 2 | 0.320 |
Why?
|
| Respiration, Artificial | 6 | 2021 | 458 | 0.310 |
Why?
|
| Anesthesia | 1 | 2011 | 213 | 0.310 |
Why?
|
| Humans | 53 | 2021 | 123259 | 0.310 |
Why?
|
| Midazolam | 1 | 2008 | 49 | 0.310 |
Why?
|
| Child | 18 | 2021 | 24256 | 0.300 |
Why?
|
| Heart Bypass, Right | 1 | 2008 | 17 | 0.300 |
Why?
|
| Hypotension | 4 | 2012 | 177 | 0.300 |
Why?
|
| Brain | 7 | 2019 | 2966 | 0.300 |
Why?
|
| Anesthetics, Combined | 1 | 2007 | 7 | 0.300 |
Why?
|
| Positive-Pressure Respiration | 4 | 2012 | 82 | 0.300 |
Why?
|
| Linear Models | 5 | 2019 | 669 | 0.290 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2008 | 141 | 0.290 |
Why?
|
| Dogs | 7 | 2009 | 764 | 0.280 |
Why?
|
| Infant, Premature | 8 | 2019 | 807 | 0.270 |
Why?
|
| Pneumonia | 2 | 2012 | 325 | 0.270 |
Why?
|
| Male | 36 | 2019 | 60333 | 0.270 |
Why?
|
| Infant | 16 | 2017 | 12376 | 0.270 |
Why?
|
| Female | 35 | 2019 | 65615 | 0.270 |
Why?
|
| Tidal Volume | 3 | 2011 | 39 | 0.270 |
Why?
|
| Infant, Premature, Diseases | 3 | 2019 | 239 | 0.270 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2017 | 625 | 0.260 |
Why?
|
| Animals | 29 | 2021 | 33857 | 0.260 |
Why?
|
| Sepsis | 3 | 2009 | 476 | 0.260 |
Why?
|
| Laser-Doppler Flowmetry | 8 | 2017 | 56 | 0.260 |
Why?
|
| Clostridium perfringens | 1 | 2005 | 7 | 0.260 |
Why?
|
| Compartment Syndromes | 1 | 2006 | 31 | 0.260 |
Why?
|
| Sickle Cell Trait | 1 | 2005 | 11 | 0.260 |
Why?
|
| Diastole | 5 | 2019 | 168 | 0.260 |
Why?
|
| Abdomen | 1 | 2006 | 129 | 0.250 |
Why?
|
| Pilot Projects | 6 | 2017 | 1389 | 0.240 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 7 | 2021 | 107 | 0.230 |
Why?
|
| Prospective Studies | 11 | 2017 | 6030 | 0.230 |
Why?
|
| Analgesics, Opioid | 1 | 2008 | 403 | 0.230 |
Why?
|
| Anesthesia, Epidural | 1 | 2003 | 14 | 0.220 |
Why?
|
| Coronary Vasospasm | 1 | 2003 | 10 | 0.220 |
Why?
|
| Jugular Veins | 2 | 2014 | 75 | 0.220 |
Why?
|
| Models, Animal | 6 | 2017 | 466 | 0.210 |
Why?
|
| ROC Curve | 4 | 2013 | 558 | 0.210 |
Why?
|
| Multivariate Analysis | 5 | 2017 | 1414 | 0.200 |
Why?
|
| Logistic Models | 4 | 2017 | 1801 | 0.200 |
Why?
|
| Animals, Newborn | 10 | 2017 | 1002 | 0.200 |
Why?
|
| Clostridium Infections | 1 | 2005 | 241 | 0.200 |
Why?
|
| Cannula | 1 | 2021 | 28 | 0.190 |
Why?
|
| Heart Arrest | 2 | 2017 | 342 | 0.180 |
Why?
|
| Spectrum Analysis | 1 | 2021 | 61 | 0.180 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 3 | 2018 | 15 | 0.180 |
Why?
|
| Airway Extubation | 1 | 2021 | 67 | 0.180 |
Why?
|
| Child, Preschool | 11 | 2017 | 13918 | 0.180 |
Why?
|
| Cytokines | 3 | 2018 | 1282 | 0.180 |
Why?
|
| Disease Models, Animal | 12 | 2016 | 4298 | 0.180 |
Why?
|
| Adolescent | 11 | 2017 | 19127 | 0.180 |
Why?
|
| Pulmonary Surfactants | 2 | 2018 | 43 | 0.170 |
Why?
|
| Coronary Artery Bypass | 2 | 2013 | 490 | 0.160 |
Why?
|
| Biomarkers | 5 | 2017 | 2953 | 0.160 |
Why?
|
| Hospital Mortality | 3 | 2013 | 1013 | 0.160 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2019 | 76 | 0.150 |
Why?
|
| Algorithms | 5 | 2019 | 1598 | 0.150 |
Why?
|
| Lung Volume Measurements | 2 | 2008 | 74 | 0.150 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2018 | 27 | 0.150 |
Why?
|
| Catheterization | 2 | 2010 | 237 | 0.140 |
Why?
|
| Perioperative Care | 3 | 2017 | 195 | 0.140 |
Why?
|
| Intubation, Intratracheal | 1 | 2000 | 291 | 0.140 |
Why?
|
| Perfusion | 2 | 2019 | 200 | 0.130 |
Why?
|
| Electrocardiography | 2 | 2017 | 958 | 0.130 |
Why?
|
| Carbon Dioxide | 3 | 2011 | 273 | 0.130 |
Why?
|
| Sheep | 4 | 2012 | 209 | 0.130 |
Why?
|
| Cerebral Ventricles | 1 | 2016 | 81 | 0.130 |
Why?
|
| Heart Ventricles | 2 | 2017 | 763 | 0.120 |
Why?
|
| Electroencephalography | 2 | 2019 | 857 | 0.120 |
Why?
|
| Regression Analysis | 2 | 2019 | 772 | 0.120 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2016 | 239 | 0.120 |
Why?
|
| Growth Disorders | 1 | 2016 | 208 | 0.110 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 492 | 0.110 |
Why?
|
| Young Adult | 3 | 2013 | 8867 | 0.110 |
Why?
|
| Ketamine | 2 | 2008 | 214 | 0.110 |
Why?
|
| Ultrasonography | 3 | 2014 | 942 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 280 | 0.110 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2017 | 252 | 0.110 |
Why?
|
| Rewarming | 1 | 2013 | 12 | 0.110 |
Why?
|
| In Vitro Techniques | 2 | 2014 | 967 | 0.110 |
Why?
|
| Heart Valves | 1 | 2013 | 51 | 0.110 |
Why?
|
| Sleep Wake Disorders | 1 | 2015 | 177 | 0.110 |
Why?
|
| Aerospace Medicine | 1 | 2013 | 37 | 0.110 |
Why?
|
| Oxygen Consumption | 2 | 2011 | 307 | 0.110 |
Why?
|
| Vena Cava, Superior | 1 | 2013 | 55 | 0.110 |
Why?
|
| Respiratory Insufficiency | 2 | 2015 | 231 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 2019 | 0.110 |
Why?
|
| Echoencephalography | 1 | 2013 | 25 | 0.110 |
Why?
|
| Pain, Postoperative | 1 | 2016 | 256 | 0.100 |
Why?
|
| Erythrocyte Transfusion | 1 | 2014 | 123 | 0.100 |
Why?
|
| Medical Order Entry Systems | 1 | 2014 | 99 | 0.100 |
Why?
|
| Renal Circulation | 1 | 2012 | 45 | 0.100 |
Why?
|
| Xenon | 2 | 2009 | 11 | 0.100 |
Why?
|
| Preanesthetic Medication | 1 | 2011 | 3 | 0.100 |
Why?
|
| Respiratory Rate | 1 | 2011 | 4 | 0.100 |
Why?
|
| Renal Artery | 1 | 2012 | 74 | 0.100 |
Why?
|
| Erythropoietin | 1 | 2012 | 104 | 0.100 |
Why?
|
| Vascular Resistance | 3 | 2019 | 189 | 0.100 |
Why?
|
| Resuscitation | 1 | 2014 | 244 | 0.100 |
Why?
|
| Space Flight | 1 | 2013 | 115 | 0.100 |
Why?
|
| Functional Laterality | 1 | 2012 | 181 | 0.100 |
Why?
|
| Endotoxemia | 1 | 2012 | 57 | 0.100 |
Why?
|
| Nervous System | 1 | 2012 | 128 | 0.100 |
Why?
|
| Umbilical Arteries | 3 | 2016 | 88 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2014 | 373 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2016 | 580 | 0.090 |
Why?
|
| Body Temperature | 2 | 2009 | 113 | 0.090 |
Why?
|
| Shock | 1 | 2012 | 90 | 0.090 |
Why?
|
| Lipopolysaccharides | 2 | 2009 | 293 | 0.090 |
Why?
|
| Airway Management | 1 | 2011 | 66 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 150 | 0.090 |
Why?
|
| Gestational Age | 4 | 2016 | 1137 | 0.090 |
Why?
|
| Transposition of Great Vessels | 1 | 2012 | 131 | 0.090 |
Why?
|
| Anesthesia, General | 1 | 2011 | 112 | 0.090 |
Why?
|
| Infant, Extremely Premature | 3 | 2016 | 81 | 0.090 |
Why?
|
| Treatment Outcome | 5 | 2013 | 12169 | 0.090 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2016 | 373 | 0.090 |
Why?
|
| Retrospective Studies | 6 | 2017 | 16068 | 0.090 |
Why?
|
| Likelihood Functions | 1 | 2010 | 112 | 0.090 |
Why?
|
| Anemia, Sickle Cell | 1 | 2014 | 334 | 0.090 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2009 | 16 | 0.090 |
Why?
|
| Oxygen | 2 | 2011 | 550 | 0.090 |
Why?
|
| Child Development | 1 | 2012 | 260 | 0.080 |
Why?
|
| Renal Insufficiency | 1 | 2012 | 234 | 0.080 |
Why?
|
| United States | 2 | 2017 | 10652 | 0.080 |
Why?
|
| Risk | 1 | 2011 | 747 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 228 | 0.080 |
Why?
|
| Conscious Sedation | 1 | 2009 | 63 | 0.080 |
Why?
|
| Intracranial Hypotension | 1 | 2008 | 10 | 0.080 |
Why?
|
| Biophysics | 1 | 2008 | 49 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2012 | 372 | 0.080 |
Why?
|
| Risk Factors | 5 | 2019 | 10035 | 0.080 |
Why?
|
| Nursing Assessment | 1 | 2008 | 26 | 0.080 |
Why?
|
| Pressure | 1 | 2008 | 129 | 0.080 |
Why?
|
| Hydrochloric Acid | 1 | 2008 | 14 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2012 | 482 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2012 | 1473 | 0.080 |
Why?
|
| Supine Position | 1 | 2008 | 24 | 0.070 |
Why?
|
| Anesthetics, Dissociative | 1 | 2008 | 20 | 0.070 |
Why?
|
| Propofol | 1 | 2007 | 44 | 0.070 |
Why?
|
| Respiratory Mechanics | 1 | 2008 | 75 | 0.070 |
Why?
|
| Aorta, Thoracic | 1 | 2012 | 519 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2011 | 492 | 0.070 |
Why?
|
| Kidney Function Tests | 1 | 2008 | 126 | 0.070 |
Why?
|
| Developmental Disabilities | 1 | 2012 | 702 | 0.070 |
Why?
|
| Lung Diseases | 2 | 2008 | 378 | 0.070 |
Why?
|
| Factor VIIa | 1 | 2006 | 24 | 0.070 |
Why?
|
| Postoperative Period | 1 | 2007 | 333 | 0.070 |
Why?
|
| Analgesics | 1 | 2007 | 134 | 0.070 |
Why?
|
| Models, Biological | 1 | 2011 | 1450 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 726 | 0.070 |
Why?
|
| Critical Care | 1 | 2011 | 648 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 1013 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2013 | 615 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2006 | 355 | 0.060 |
Why?
|
| Pulmonary Artery | 1 | 2008 | 439 | 0.060 |
Why?
|
| Stroke | 1 | 2012 | 958 | 0.060 |
Why?
|
| Severity of Illness Index | 4 | 2016 | 2854 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2005 | 463 | 0.060 |
Why?
|
| Prevalence | 1 | 2011 | 2409 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 1003 | 0.060 |
Why?
|
| Middle Aged | 8 | 2013 | 26087 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 2012 | 1026 | 0.060 |
Why?
|
| Adult | 4 | 2012 | 29098 | 0.060 |
Why?
|
| Angina, Unstable | 1 | 2003 | 52 | 0.050 |
Why?
|
| Cardiac Catheterization | 1 | 2008 | 630 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2006 | 458 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2006 | 1681 | 0.050 |
Why?
|
| Pediatrics | 1 | 2011 | 1141 | 0.050 |
Why?
|
| Hemodynamics | 2 | 2019 | 843 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2016 | 1245 | 0.050 |
Why?
|
| Predictive Value of Tests | 3 | 2013 | 2114 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2013 | 1012 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2006 | 983 | 0.040 |
Why?
|
| Aged | 6 | 2013 | 19195 | 0.040 |
Why?
|
| Pregnancy | 1 | 2013 | 7129 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 3549 | 0.040 |
Why?
|
| Hemodilution | 1 | 2019 | 15 | 0.040 |
Why?
|
| Oxyhemoglobins | 1 | 2019 | 22 | 0.040 |
Why?
|
| Time Factors | 3 | 2015 | 6223 | 0.040 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2019 | 41 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2016 | 4701 | 0.040 |
Why?
|
| Patient Admission | 1 | 2000 | 183 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2012 | 151 | 0.040 |
Why?
|
| Blood Gas Analysis | 2 | 2009 | 82 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2018 | 36 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2019 | 315 | 0.030 |
Why?
|
| Texas | 2 | 2017 | 3557 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2012 | 6392 | 0.030 |
Why?
|
| Coronary Care Units | 1 | 2016 | 36 | 0.030 |
Why?
|
| Apgar Score | 1 | 2016 | 47 | 0.030 |
Why?
|
| Feeding Methods | 1 | 2016 | 37 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2016 | 57 | 0.030 |
Why?
|
| Analgesia | 1 | 2016 | 44 | 0.030 |
Why?
|
| Failure to Thrive | 1 | 2016 | 90 | 0.030 |
Why?
|
| Systole | 1 | 2016 | 196 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 862 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 667 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 2016 | 180 | 0.030 |
Why?
|
| Histones | 1 | 2018 | 528 | 0.030 |
Why?
|
| Pain Management | 1 | 2016 | 176 | 0.030 |
Why?
|
| Seizures | 1 | 2019 | 874 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 2398 | 0.030 |
Why?
|
| Surgical Instruments | 1 | 2014 | 56 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 1290 | 0.030 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2013 | 17 | 0.030 |
Why?
|
| Central Venous Pressure | 1 | 2013 | 25 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2013 | 314 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 2844 | 0.030 |
Why?
|
| Sleep | 1 | 2015 | 350 | 0.030 |
Why?
|
| Lung Compliance | 1 | 2012 | 19 | 0.030 |
Why?
|
| Operative Time | 1 | 2013 | 161 | 0.030 |
Why?
|
| Blood Volume Determination | 1 | 2012 | 9 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 1385 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2012 | 235 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 158 | 0.020 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2011 | 13 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 3289 | 0.020 |
Why?
|
| Reperfusion Injury | 1 | 2011 | 103 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 395 | 0.020 |
Why?
|
| Respiratory-Gated Imaging Techniques | 1 | 2009 | 1 | 0.020 |
Why?
|
| Coma | 1 | 2009 | 54 | 0.020 |
Why?
|
| Mice | 3 | 2018 | 17560 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 2009 | 203 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2009 | 104 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 4369 | 0.020 |
Why?
|
| Posture | 1 | 2009 | 152 | 0.020 |
Why?
|
| Physiology | 1 | 2008 | 14 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 926 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2008 | 125 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 2008 | 79 | 0.020 |
Why?
|
| Diuresis | 1 | 2008 | 58 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 1737 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2008 | 169 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2008 | 179 | 0.020 |
Why?
|
| Respiration | 1 | 2008 | 122 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2008 | 134 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2008 | 425 | 0.020 |
Why?
|
| Vitamin K Deficiency | 1 | 2006 | 3 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2009 | 258 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2009 | 242 | 0.020 |
Why?
|
| Quality of Life | 1 | 2016 | 1933 | 0.020 |
Why?
|
| Creatinine | 1 | 2008 | 382 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2006 | 171 | 0.020 |
Why?
|
| Blood Coagulation Disorders | 1 | 2006 | 99 | 0.020 |
Why?
|
| Species Specificity | 1 | 2006 | 550 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 577 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2008 | 471 | 0.020 |
Why?
|
| Heart Rate | 1 | 2008 | 587 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2008 | 482 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 3053 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 850 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2005 | 383 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2006 | 223 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 1093 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 1142 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 892 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2005 | 623 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 701 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 5056 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 516 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 1584 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 2811 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 2695 | 0.010 |
Why?
|
| Prognosis | 1 | 2009 | 4511 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 1566 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 3867 | 0.010 |
Why?
|
| Cell Line | 1 | 2005 | 2772 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 3666 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2006 | 1022 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2004 | 2586 | 0.010 |
Why?
|